TY  - JOUR
T1  - Physician acquiescence to patient demands for brand-name drugs: Results of a national survey of physicians
AU  - Campbell EG, Pham-Kanter G, Vogeli C, Iezzoni LI
Y1  - 2013/02/11
N1  - 10.1001/jamainternmed.2013.1539
JO  - JAMA Internal Medicine
SP  - 237
EP  - 239
VL  - 173
IS  - 3
N2  - 
Prescribing brand-name drugs when generic drugs are available generates unnecessary medical expenditures, the costs of which are borne by the public in the form of higher copayments, increased health insurance costs, and higher Medicare and Medicaid expenses.1- 2 Pharmaceutical companies aim to stimulate patients' requests for brand-name medications and increase the likelihood physicians will honor such requests.3- 4 Presently, little is known about how frequently physicians comply with such a request or the factors predicting this behavior.

SN  - 2168-6106
M3  - doi: 10.1001/jamainternmed.2013.1539
UR  - http://dx.doi.org/10.1001/jamainternmed.2013.1539
ER  -